Duality Biotherapeutics, Inc.
9606.HK News Today: Stay Updated with the Latest Duality Biotherapeutics, Inc. News in Real Time
Find 9606.HK news now at Meyka AI. Stay informed with the latest Duality Biotherapeutics, Inc. stocks updates, including price news, market analysis, and expert insights.
Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026
Jefferies maintained Buy on CTMX March 18, 2026. Read CTMX analyst rating, $16 PT, and Meyka AI grade B+
V-cube (3681.T JPX) drops 41.67% to JPY 70.00 intraday on 02 Apr 2026: Key levels
Intraday report: 3681.T stock down 41.67% to JPY 70 on 02 Apr 2026, analysis of drivers, outlook and Meyka AI forecast
Leerink Maintains Outperform on BrightSpring Health Services (BTSG) March 2026
Leerink maintained Outperform on BrightSpring (BTSG) on March 18, 2026 — coverage and investor implications for BTSG analyst rating
Morgan Stanley Maintains Overweight on Autodesk (ADSK) March 2026
Morgan Stanley keeps Overweight on Autodesk; read the ADSK analyst rating update and Meyka AI grade A
DMN Damon Inc. NASDAQ 01 Apr 2026 market closed: $0.0017 close, volume spike signals liquidity risk
DMN stock closes at $0.0017 on 01 Apr 2026 with huge volume. Quick analysis, Meyka AI grade, forecast and key risks for DMN stock.
Jefferies Maintains Buy on InterDigital (IDCC) Mar 18, 2026
Jefferies maintains Buy on InterDigital. Read our IDCC analyst rating analysis, implications, and Meyka grade for March 2026.
Raymond James Maintains Strong Buy on Electrovaya Inc (ELVA) March 2026
ELVA analyst rating: Raymond James maintains Strong Buy on Electrovaya Inc on March 18, 2026
4488.T AI inside Inc. JPX up 4.08% intraday 02 Apr 2026: watch JPY 2,200 support
Intraday look at 4488.T stock at JPY 2,295.00 on 02 Apr 2026 with Meyka AI forecast and trading levels
Market closed 01 Apr 2026: EAGR.TO down 33% to C$0.18, debt focus
EAGR.TO stock fell 33% to C$0.18 on Q4 results and strategy shift. Meyka AI forecast sees modest upside of 6.56% versus current price